Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)Seeking Alpha • 09/27/23
Waters Has Made Progress In Repositioning The Business, And The Valuation Is Much More Accommodating NowSeeking Alpha • 09/27/23
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological TherapiesPRNewsWire • 09/20/23
Waters Corporation (WAT) Bank of America Global Healthcare Conference 2023 (Transcript)Seeking Alpha • 09/15/23
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture MediaPRNewsWire • 09/12/23
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023PRNewsWire • 08/30/23
Waters (WAT) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 08/02/23
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy ApplicationsPRNewsWire • 08/01/23
Waters Corporation and Princeton University Announce Multi-Year Research CollaborationPRNewsWire • 06/26/23
Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS ImagingPRNewsWire • 06/05/23
Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute SystemPRNewsWire • 06/05/23
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream BiomanufacturingPRNewsWire • 06/05/23
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt TechnologyPRNewsWire • 05/16/23